Novelion Therapeutics Inc
Change company Symbol lookup
Select an option...
NVLN Novelion Therapeutics Inc
SOLCF SOL Global Investments Corp
MLTI Credit Suisse X-Links Multi-Asset High Income ETN
JPM-E JPMorgan Chase & Co
BSET Bassett Furniture Industries Inc
INDB Independent Bank Corp
CPHI China Pharma Holdings Inc
DRWB Laurel Road Bank
JVA Coffee Holding Co Inc
PFNX Pfenex Inc
Go

Health Care : Biotechnology |
Based in CanadaCompany profile

Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.

Closing Price
$0.9701
Day's Change
-0.0149 (-1.51%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.02
Day's Low
0.9608
Volume
(Light)
Volume:
129,631

10-day average volume:
249,321
129,631
  • Prev Close
    0.985
  • Today's Open
    1.00
  • Day's Range
    0.9608-1.02
  • Avg Vol (10-day)
    249.3K
  • Last (time)
    3:36p ET 01/18/19
  • Last (size)
    20
  • 52-Wk Range
    0.70 - 5.87
    LowHigh
  • (01/31/18 - 11/07/18)
    38.59%
  • 116.7%
  • Market Cap
    18.4M
  • Shares Outstanding
    18.9M
  • -6.05
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 2.1
  • 67.48
  • (% of float 12/31/18)
    3.73

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.